Market Scorecard
Market Pathways Scorecard: Q1 FDA Authorizations
A graphical look at FDA novel device approvals, 510(k)s, and PMA supplements during the first quarter of 2026.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Start-Ups to Watch
ABILITY Neurotech: Unlocking the Potential of BCI
A Swiss start-up spun out of a leading neuroscience research center brings advanced brain-computer interfaces out of the lab and into patients’ heads to help them overcome the limitations of disability.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
ICYMI
Treating Heart Failure Systemically
Next-gen start-ups treat heart failure tap into physiological mechanisms to help patients. Excerpted from our recent feature article.